Rapid expansion and international spread of M1

Streptococcus pyogenes / genetics United Kingdom / epidemiology Humans Streptococcal Infections / epidemiology Phylogeny COVID-19 / epidemiology Pandemics Scarlet Fever / epidemiology Mutation Repressor Proteins / genetics SARS-CoV-2 / genetics Genome, Bacterial Europe / epidemiology Bacterial Proteins

Journal

Nature communications

ISSN: 2041-1723

Titre abrégé: Nat Commun

Pays: England

ID NLM: 101528555

Informations de publication

Date de publication:
10 May 2024

Historique:

received: 12 01 2024

accepted: 15 04 2024

medline: 11 5 2024

pubmed: 11 5 2024

entrez: 10 5 2024

Statut: epublish

Résumé

The UK observed a marked increase in scarlet fever and invasive group A streptococcal infection in 2022 with severe outcomes in children and similar trends worldwide. Here we report lineage M1

Identifiants

DOI: 10.1038/s41467-024-47929-7 PMID: 38729927

pubmed: 38729927

doi: 10.1038/s41467-024-47929-7

pii: 10.1038/s41467-024-47929-7

doi:

Substances chimiques

CsrR protein, Streptococcus pyogenes 0

Repressor Proteins 0

Bacterial Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

Pagination

3916

Subventions

Organisme : RCUK | Medical Research Council (MRC)

ID : MR/P022669/1

Organisme : RCUK | Medical Research Council (MRC)

ID : MR/X001962/1

Informations de copyright

Références

Brouwer, S. et al. Pathogenesis, epidemiology and control of group A Streptococcus infection. Nat. Rev. Microbiol 21, 431–447 (2023).

pubmed: 36894668 pmcid: 9998027 doi: 10.1038/s41579-023-00865-7

Nelson, G. E. et al. Epidemiology of invasive group A Streptococcal infections in the United States, 2005–2012. Clin. Infect. Dis. 63, 478–486 (2016).

pubmed: 27105747 doi: 10.1093/cid/ciw248

Lamagni, T. L. et al. Predictors of death after severe Streptococcus pyogenes infection. Emerg. Infect. Dis. 15, 1304–1307 (2009).

pubmed: 19751599 doi: 10.3201/eid1508.090264

Steer, A. C., Law, I., Matatolu, L., Beall, B. W. & Carapetis, J. R. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9, 611–616 (2009).

pubmed: 19778763 doi: 10.1016/S1473-3099(09)70178-1

Lynskey, N. N. et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect. Dis. 19, 1209–1218 (2019).

pubmed: 31519541 pmcid: 6838661 doi: 10.1016/S1473-3099(19)30446-3

Li, H. K. et al. Characterization of emergent toxigenic M1UK Streptococcus pyogenes and associated sublineages. Microb. Genomics 9, mgen000994 (2023).

doi: 10.1099/mgen.0.000994

Sumby, P., Whitney, A. R., Graviss, E. A., DeLeo, F. R. & Musser, J. M. Genome-wide analysis of group A Streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2, e5 (2006).

pubmed: 16446783 pmcid: 1354197 doi: 10.1371/journal.ppat.0020005

Nasser, W. et al. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc. Natl Acad. Sci. USA 111, 17 (2014).

doi: 10.1073/pnas.1403138111

National Institute for Health and Care Excellence (NICE). management of scarlet fever. https://cks.nice.org.uk/topics/scarlet-fever/management/management/ (2023).

Tan, T., Little, P. & Stokes, T. Antibiotic prescribing for self-limiting respiratory tract infections in primary care: summary of NICE guidance. Br. Med. J. 337, a437 (2008).

doi: 10.1136/bmj.a437

Lamagni, T. et al. Resurgence of scarlet fever in England, 2014–16: a population-based surveillance study. Lancet Infect. Dis. 18, 180–187 (2018).

pubmed: 29191628 doi: 10.1016/S1473-3099(17)30693-X

UK Health Security Agency. Group A streptococcal infections: 15th update on seasonal activity in England https://www.gov.uk/government/publications/group-a-streptococcal-infections-activity-during-the-2022-to-2023-season/group-a-streptococcal-infections-15th-update-on-seasonal-activity-in-england (2023).

Davies, M. R. et al. Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat. Commun. 14, 1051 (2023).

pubmed: 36828918 pmcid: 9951164 doi: 10.1038/s41467-023-36717-4

Zhi, X. et al. Emerging Invasive Group A Streptococcus M1

pubmed: 37019153 pmcid: 10124639 doi: 10.3201/eid2905.221887

Guy, R. et al. Increase in invasive group A streptococcal infection notifications, England, 2022. Eurosurveillance 28, 2200942 (2023).

pubmed: 36695450 pmcid: 9817207 doi: 10.2807/1560-7917.ES.2023.28.1.2200942

WHO. Increased incidence of scarlet fever and invasive Group A Streptococcus infection - multi-country. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON429 (2022).

Gov.UK. Group A streptococcal infections: report on seasonal activity in England, 2023 to 2024 https://www.gov.uk/government/publications/group-a-streptococcal-infections-report-on-seasonal-activity-in-england-2023-to-2024/group-a-streptococcal-infections-report-on-seasonal-activity-in-england-2023-to-2024 (2024).

Chen, M. et al. Increase of emm1 isolates among group A Streptococcus strains causing scarlet fever in Shanghai, China. Int. J. Infect. Dis. 98, 305–314 (2020).

pubmed: 32562850 doi: 10.1016/j.ijid.2020.06.053

Vannice, K. S. et al. Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to β-Lactam Antibiotics. Clin. Infect. Dis. 71, 201–204 (2020).

pubmed: 31630171 doi: 10.1093/cid/ciz1000

Musser, J. M. et al. Reduced in vitro susceptibility of Streptococcus pyogenes to β-Lactam antibiotics associated with mutations in the pbp2x gene is geographically widespread. J. Clin. Microbiol 58, e01993–19 (2020).

pubmed: 31996443 pmcid: 7098749 doi: 10.1128/JCM.01993-19

Johannesen, T. B. et al. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Eurosurveillance 28, 2300291 (2023).

pubmed: 37382884 pmcid: 10311951 doi: 10.2807/1560-7917.ES.2023.28.26.2300291

Rümke, L. W. et al. Dominance of M1UK clade among Dutch M1 Streptococcus pyogenes. Lancet Infect. Dis. 20, 539–540 (2020).

pubmed: 32359464 doi: 10.1016/S1473-3099(20)30278-4

Turner, C. E. et al. The Emergence of Successful Streptococcus pyogenes Lineages through Convergent Pathways of Capsule Loss and Recombination Directing High Toxin Expression. Mbio 10, e02521–19 (2019).

pubmed: 31822586 pmcid: 6904876 doi: 10.1128/mBio.02521-19

Demczuk, W., Martin, I., Domingo, F. R., MacDonald, D. & Mulvey, M. R. Identification of Streptococcus pyogenes M1UK clone in Canada. Lancet Infect. Dis. 19, 1284–1285 (2019).

pubmed: 31782392 doi: 10.1016/S1473-3099(19)30622-X

Li, Y., Nanduri, S. A., Van Beneden, C. A. & Beall, B. W. M1UK lineage in invasive group A streptococcus isolates from the USA. Lancet Infect. Dis. 20, 538–539 (2020).

pubmed: 32359463 pmcid: 9052193 doi: 10.1016/S1473-3099(20)30279-6

De Gier, B. et al. Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Eurosurveillance 28, 2200941 (2023).

pubmed: 36695447 pmcid: 9817208

Lassoued, Y. et al. Unexpected increase in invasive group A Streptococcal infections in children after respiratory viruses outbreak in France: a 15-Year time-series analysis. Open Forum Infect. Dis. 10, ofad188 (2023).

pubmed: 37180594 pmcid: 10167988 doi: 10.1093/ofid/ofad188

Rodriguez-Ruiz, J. P. et al. Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1UK, Belgium, May 2022 to August 2023. Eurosurveillance 28, 2300422 (2023).

pubmed: 37676145 pmcid: 10486196 doi: 10.2807/1560-7917.ES.2023.28.36.2300422

Gouveia, C. et al. Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023. Eurosurveillance 28, 2300427 (2023).

pubmed: 37676143 pmcid: 10486195 doi: 10.2807/1560-7917.ES.2023.28.36.2300427

Aboulhosn A., et al. Increases in group A Streptococcal infections in the pediatric population in Houston, TX, 2022. Clin Infect Dis. 77, 351–354 (2023).

Bessen, D. E. Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect., Genet. Evolution 9, 581–593 (2009).

doi: 10.1016/j.meegid.2009.03.002

Cordery, R. et al. Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK. Lancet Microbe 3, e366–e375 (2022).

pubmed: 35544097 pmcid: 9042792 doi: 10.1016/S2666-5247(21)00332-3

Mayfield, J. A. et al. Mutations in the control of virulence sensor gene from Streptococcus pyogenes after Infection in mice lead to clonal bacterial variants with altered gene regulatory activity and virulence. PLoS ONE 9, e100698 (2014).

pubmed: 24968349 pmcid: 4072638 doi: 10.1371/journal.pone.0100698

Gulliford, M. et al. Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006. J. Public Health 31, 512–520 (2009).

doi: 10.1093/pubmed/fdp081

Yap, D., Harris, A. & Clarke, J. Serious tonsil infections versus tonsillectomy rates in Wales: A 15-year analysis. annals 99, 31–36 (2017).

doi: 10.1308/rcsann.2016.0261

Tamayo, E., Montes, M., García-Arenzana, J. M. & Pérez-Trallero, E. Streptococcus pyogenes emm-types in northern Spain; population dynamics over a 7-year period. J. Infect. 68, 50–57 (2014).

pubmed: 23999149 doi: 10.1016/j.jinf.2013.08.013

Shaw, D. et al. Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium. Lancet Digit Health 9, e582–e593 (2023).

doi: 10.1016/S2589-7500(23)00108-5

Hollingsworth, B., Okamoto, K. W. & Lloyd, A. L. After the honeymoon, the divorce: Unexpected outcomes of disease control measures against endemic infections. PLoS Comput Biol. 16, e1008292 (2020).

pubmed: 33075052 pmcid: 7595641 doi: 10.1371/journal.pcbi.1008292

Herdman, M. T. et al. Clinical management and impact of scarlet fever in the modern era: findings from a cross-sectional study of cases in London, 2018–2019. BMJ Open 11, e057772 (2022).

doi: 10.1136/bmjopen-2021-057772

Department of Health. Health Protection Legislation (England) Guidance 2010 England. https://webarchive.nationalarchives.gov.uk/ukgwa/20130105053557/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_114589.pdf (2010).

Kapatai, G., Coelho, J., Platt, S. & Chalker, V. J. Whole genome sequencing of group A Streptococcus: development and evaluation of an automated pipeline for emm gene typing. PeerJ 5, e3226 (2017).

pubmed: 28462035 pmcid: 5410157 doi: 10.7717/peerj.3226

Ruan, J. & Li, H. Fast and accurate long-read assembly with wtdbg2. Nat. Methods 17, 155–158 (2020).

pubmed: 31819265 doi: 10.1038/s41592-019-0669-3

Wick, R. R. et al. Trycycler: consensus long-read assemblies for bacterial genomes. Genome Biol. 22, 266 (2021).

pubmed: 34521459 pmcid: 8442456 doi: 10.1186/s13059-021-02483-z

Mikheenko, A., Prjibelski, A., Saveliev, V., Antipov, D. & Gurevich, A. Versatile genome assembly evaluation with QUAST-LG. Bioinformatics 34, i142–i150 (2018).

pubmed: 29949969 pmcid: 6022658 doi: 10.1093/bioinformatics/bty266

Manni, M., Berkeley, M. R., Seppey, M., Simão, F. A. & Zdobnov, E. M. BUSCO Update: Novel and streamlined workflows along with broader and deeper phylogenetic coverage for scoring of eukaryotic, prokaryotic, and viral genomes. Mol. Biol. Evolution 38, 4647–4654 (2021).

doi: 10.1093/molbev/msab199

Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069 (2014).

pubmed: 24642063 doi: 10.1093/bioinformatics/btu153

Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).

pubmed: 24695404 pmcid: 4103590 doi: 10.1093/bioinformatics/btu170

Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).

pubmed: 31779668 pmcid: 6883579 doi: 10.1186/s13059-019-1891-0

Bankevich, A. et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing. J. Computational Biol. 19, 455–477 (2012).

doi: 10.1089/cmb.2012.0021

Croucher, N. J. et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 43, e15 (2015).

pubmed: 25414349 doi: 10.1093/nar/gku1196

Kozlov, A. M., Darriba, D., Flouri, T., Morel, B. & Stamatakis, A. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics 35, 4453–4455 (2019).

pubmed: 31070718 pmcid: 6821337 doi: 10.1093/bioinformatics/btz305

Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 49, W293–W296 (2021).

pubmed: 33885785 pmcid: 8265157 doi: 10.1093/nar/gkab301

Hunt, M. et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb. Genomics 3, e000131 (2017).

doi: 10.1099/mgen.0.000131

Inouye, M. et al. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med 6, 90 (2014).

pubmed: 25422674 pmcid: 4237778 doi: 10.1186/s13073-014-0090-6

Tonkin-Hill, G. et al. Producing polished prokaryotic pangenomes with the Panaroo pipeline. Genome Biol. 21, 180 (2020).

pubmed: 32698896 pmcid: 7376924 doi: 10.1186/s13059-020-02090-4

Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498–2504 (2003).

pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303

Minh, B. Q. et al. IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evolution 37, 1530–1534 (2020).

doi: 10.1093/molbev/msaa015

To, T.-H., Jung, M., Lycett, S. & Gascuel, O. Fast dating using least-squares criteria and algorithms. Syst. Biol. 65, 82–97 (2016).

pubmed: 26424727 doi: 10.1093/sysbio/syv068

Ishikawa, S. A., Zhukova, A., Iwasaki, W. & Gascuel, O. A fast likelihood method to reconstruct and visualize ancestral scenarios. Mol. Biol. Evolution 36, 2069–2085 (2019).

doi: 10.1093/molbev/msz131

Didelot, X., Franceschi, V., Frost, S. D. W., Dennis, A. & Volz, E. M. Model design for nonparametric phylodynamic inference and applications to pathogen surveillance. Virus Evolution 9, vead028 (2023).

pubmed: 37229349 pmcid: 10205094 doi: 10.1093/ve/vead028

Volz, E. M. & Didelot, X. Modeling the growth and decline of pathogen effective population size provides insight into epidemic dynamics and drivers of antimicrobial resistance. Syst. Biol. 67, 719–728 (2018).

pubmed: 29432602 pmcid: 6005154 doi: 10.1093/sysbio/syy007